ArticleHaematologica2012

Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.

Susanne Schnittger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.